share_log

药康生物(688046.SH):前三季度实现净利润9821.44万元

Yao Kang Biology (688046.SH): Achieved net income of 98.2144 million yuan in the first three quarters.

Gelonghui Finance ·  Oct 30 22:22

On October 30, Gelonhui announced that Pharmaron Biotech (688046.SH) released a statement, achieving revenue of 0.51 billion yuan in the first three quarters of 2024, an increase of 12.13% year-on-year; the net income attributable to shareholders of the listed company was 98.2144 million yuan, a decrease of 16.57% year-on-year, with basic earnings per share of 0.24 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment